Bharat Budholia
Senior Partner
MumbaiPractice Area
I am passionate about my work and vigorously strive to achieve best possible results for my clients. I build long-term relationships with my clients and provide them with business-oriented advice and creative solutions to legal challenges.
Bharat Budholia in Mumbai is widely respected by clients and often advises in the High Court on abuse of dominance cases, as well as Indian merger control proceedings. “He is extremely quick and thinks on his feet in the most complex of situations. His expertise in the field of competition law has helped us in several critical scenarios over the past few years.”
Chambers & Partners Global (2025)Bharat Budholia has over 16 years of experience and specializes in Competition / Antitrust matters. He advises clients on the full spectrum of competition issues, including cartel enforcement, abuse of dominance and merger control. Bharat has represented domestic and multinational clients across diverse sectors, including financial services, aviation, pharmaceuticals, consumer goods, cement, banking, healthcare, insurance, sports, media, energy, transport and telecom.
WORK HIGHLIGHTS
-
On its investment into Intas Pharmaceutical
-
On its two abuse of dominance cases before Competition Commission of India and National Company Law Appellate Tribunal
-
On its US$ 1.78 billion acquisition of Viacom 18
-
On its merger with and into HDFC Bank
-
On the US$ 10 billion sale of its shareholding in Ambuja Cements Limited and ACC Limited to Adani Group
-
On its US$ 2.4 billion acquisition of Air India Limited
-
On its investment into Intas Pharmaceutical
-
On its two abuse of dominance cases before Competition Commission of India and National Company Law Appellate Tribunal
-
On its US$ 1.78 billion acquisition of Viacom 18
-
On its merger with and into HDFC Bank
-
On the US$ 10 billion sale of its shareholding in Ambuja Cements Limited and ACC Limited to Adani Group
-
On its US$ 2.4 billion acquisition of Air India Limited
-
On its investment into Intas Pharmaceutical
-
On its two abuse of dominance cases before Competition Commission of India and National Company Law Appellate Tribunal
-
On its US$ 1.78 billion acquisition of Viacom 18
-
On its merger with and into HDFC Bank
-
On the US$ 10 billion sale of its shareholding in Ambuja Cements Limited and ACC Limited to Adani Group
-
On its US$ 2.4 billion acquisition of Air India Limited
-
On its investment into Intas Pharmaceutical
-
On its two abuse of dominance cases before Competition Commission of India and National Company Law Appellate Tribunal
-
On its US$ 1.78 billion acquisition of Viacom 18
-
On its merger with and into HDFC Bank
-
On the US$ 10 billion sale of its shareholding in Ambuja Cements Limited and ACC Limited to Adani Group
-
On its US$ 2.4 billion acquisition of Air India Limited
-
On its investment into Intas Pharmaceutical
-
On its two abuse of dominance cases before Competition Commission of India and National Company Law Appellate Tribunal
-
On its US$ 1.78 billion acquisition of Viacom 18
-
On its merger with and into HDFC Bank
-
On the US$ 10 billion sale of its shareholding in Ambuja Cements Limited and ACC Limited to Adani Group
-
On its US$ 2.4 billion acquisition of Air India Limited
-
On its investment into Intas Pharmaceutical
-
On its two abuse of dominance cases before Competition Commission of India and National Company Law Appellate Tribunal
-
On its US$ 1.78 billion acquisition of Viacom 18
-
On its merger with and into HDFC Bank
-
On the US$ 10 billion sale of its shareholding in Ambuja Cements Limited and ACC Limited to Adani Group
-
On its US$ 2.4 billion acquisition of Air India Limited
-
On its investment into Intas Pharmaceutical
-
On its two abuse of dominance cases before Competition Commission of India and National Company Law Appellate Tribunal
-
On its US$ 1.78 billion acquisition of Viacom 18
-
On its merger with and into HDFC Bank
-
On the US$ 10 billion sale of its shareholding in Ambuja Cements Limited and ACC Limited to Adani Group
-
On its US$ 2.4 billion acquisition of Air India Limited
-
On its investment into Intas Pharmaceutical
-
On its two abuse of dominance cases before Competition Commission of India and National Company Law Appellate Tribunal
-
On its US$ 1.78 billion acquisition of Viacom 18
-
On its merger with and into HDFC Bank
-
On the US$ 10 billion sale of its shareholding in Ambuja Cements Limited and ACC Limited to Adani Group
-
On its US$ 2.4 billion acquisition of Air India Limited
-
On its investment into Intas Pharmaceutical
-
On its two abuse of dominance cases before Competition Commission of India and National Company Law Appellate Tribunal
-
On its US$ 1.78 billion acquisition of Viacom 18
-
On its merger with and into HDFC Bank
-
On the US$ 10 billion sale of its shareholding in Ambuja Cements Limited and ACC Limited to Adani Group
-
On its US$ 2.4 billion acquisition of Air India Limited
-
On its investment into Intas Pharmaceutical
-
On its two abuse of dominance cases before Competition Commission of India and National Company Law Appellate Tribunal
-
On its US$ 1.78 billion acquisition of Viacom 18
-
On its merger with and into HDFC Bank
-
On the US$ 10 billion sale of its shareholding in Ambuja Cements Limited and ACC Limited to Adani Group
-
On its US$ 2.4 billion acquisition of Air India Limited
-
On its investment into Intas Pharmaceutical
-
On its two abuse of dominance cases before Competition Commission of India and National Company Law Appellate Tribunal
-
On its US$ 1.78 billion acquisition of Viacom 18
-
On its merger with and into HDFC Bank
-
On the US$ 10 billion sale of its shareholding in Ambuja Cements Limited and ACC Limited to Adani Group
-
On its US$ 2.4 billion acquisition of Air India Limited
RECENT RECOGNITION
2025
2024
2023
2022
Chambers & Partners Asia-Pacific
Ranked for Competition/Antitrust
Chambers & Partners Global
Ranked for Competition/Antitrust
Legal 500 Asia Pacific
Named a ‘Next Generation Partner’ for Competition/Antitrust
Asialaw Profiles
‘Distinguished Practitioner’ for Competition/ Antitrust
Chambers & Partners Asia-Pacific
Ranked for Competition/Antitrust
Chambers & Partners Global
Ranked for Competition/Antitrust
Legal 500 Asia Pacific
Recommended for Competition/Antitrust
Who’s Who Legal
Recommended Lawyer for Competition Law
Chambers & Partners Asia-Pacific
Ranked for Competition/Antitrust
Chambers & Partners Global
Ranked for Competition/Antitrust
Legal 500 Asia Pacific
Recommended for Competition/Antitrust
Legal Era
Named a Leading Lawyer for Antitrust & Competition
Chambers & Partners Asia-Pacific
Ranked for Competition/Antitrust
Chambers & Partners Global
Ranked for Competition/Antitrust
Legal 500 Asia Pacific
Recommended for Competition/Antitrust
Legal Era
Named a Leading Lawyer for Antitrust & Competition
Who’s Who Legal
- Named a ‘Competition Lawyer’
- Recommended for Competition in the Global Guide
RECENT RECOGNITION
Chambers & Partners Asia-Pacific
Ranked for Competition/Antitrust
Chambers & Partners Global
Ranked for Competition/Antitrust
Legal 500 Asia Pacific
Named a ‘Next Generation Partner’ for Competition/Antitrust
Asialaw Profiles
‘Distinguished Practitioner’ for Competition/ Antitrust
Chambers & Partners Asia-Pacific
Ranked for Competition/Antitrust
Chambers & Partners Global
Ranked for Competition/Antitrust
Legal 500 Asia Pacific
Recommended for Competition/Antitrust
Who’s Who Legal
Recommended Lawyer for Competition Law
Chambers & Partners Asia-Pacific
Ranked for Competition/Antitrust
Chambers & Partners Global
Ranked for Competition/Antitrust
Legal 500 Asia Pacific
Recommended for Competition/Antitrust
Legal Era
Named a Leading Lawyer for Antitrust & Competition
Chambers & Partners Asia-Pacific
Ranked for Competition/Antitrust
Chambers & Partners Global
Ranked for Competition/Antitrust
Legal 500 Asia Pacific
Recommended for Competition/Antitrust
Legal Era
Named a Leading Lawyer for Antitrust & Competition
Who’s Who Legal
- Named a ‘Competition Lawyer’
- Recommended for Competition in the Global Guide